Prof. Marcy Zenobi-Wong is a Full Professor at ETH Zurich's Department of Health Sciences and Technology, specializing in biofabrication and tissue engineering. Her research focuses on cartilage regeneration using advanced biomaterials, including nanofilm coatings and 3D printing techniques. She holds patents in tissue engineering and has pioneered methods like filamented light (FLight) biofabrication for creating anisotropic tissues. Her academic journey includes a B.Sc. from MIT (1985), M.Sc. and Ph.D. from Stanford (1987, 1990), followed by postdoctoral work at the University of Michigan. She leads the Biofabrication Group at ETH, developing therapies for joint repair and regenerative medicine. Courses taught include Biomedical Engineering and Materials and Mechanics in Medicine . Research highlights include engineered hydrogels for cartilage protection, CRISPR-driven gene editing in chondrocytes, and biohybrid neural interfaces. Her work bridges material science, cell biology, and clinical applications, with a focus on translational medicine. Collaborative projects involve creating elastic cartilage grafts for microtia reconstruction and volumetric printing of complex tissue constructs.
Massachusetts Institute of TechnologyUnited States
Bradley D. Olsen is a full professor in the Department of Chemical Engineering at the Massachusetts Institute of Technology (MIT), where he leads research at the intersection of polymer science, soft matter physics, and bioengineering. His work focuses on designing materials for critical applications in biotechnology, hemostasis, and sustainable polymer development while advancing fundamental understanding of polymer network mechanics and self-assembly. Education: Ph.D. in Chemical Engineering, University of California Berkeley (2007) S.B. in Chemical Engineering, Massachusetts Institute of Technology (2003) Olsen's research spans protein-based materials, block copolymer phase behavior, and mechanochemical hydrogels. He has pioneered methods for quantifying polymer network topology, developing hemostatic nanoparticles, and creating bio-inspired materials for selective biomolecular transport and medical applications. His recent publications emphasize data-driven approaches to polymer characterization and educational outreach in materials science. Scientific Awards: American Physical Society (APS) Fellow (2023) Fulbright Amazonia Scholar (2023) Alexander and I. Michael Kasser Chair in Chemical Engineering (2021) ACS Macro Letters Young Investigator Award (2021) MIT Committed to Caring Honor (2019) AIChE Owens Corning Early Career Award (2019) APS Dillon Medal (2018) Kavli Emerging Leader in Chemistry (2017) ACS Polymer Division Fellow (2016) Camille Dreyfus-Teacher Scholar (2015) Alfred P. Sloan Research Fellow (2014) NSF Career Grant (2013) NIH Postdoctoral Fellowship (2008-2009) Hertz Fellow (2003-2007) Barry M. Goldwater Scholarship (2002) Olsen has received significant grant support including NSF Career (2013) and AFOSR (2012) awards. His teaching activities include innovative international outreach like the 2025 soccer-themed science camp in Brazil. The Olsen Group at MIT explores advanced materials with applications ranging from trauma care to sustainable polymers.
Houman Savoji is an Associate Professor in the Department of Pharmacology and Physiology at the Faculty of Medicine, University of Montreal. He is also a full-time researcher at the CHU Sainte-Justine Research Center and principal investigator in regenerative medicine, organs-on-chip, and bioprinting at TransMedTech Institute. Dr. Savoji received his PhD in Biomedical Engineering from the Institute of Biomedical Engineering at Polytechnique Montréal in 2016. He then completed a postdoctoral fellowship at the Institute of Biomaterials and Biomedical Engineering at the University of Toronto. His research expertise combines advanced manufacturing technologies (micro- and nano-fabrication, 3D bioprinting, microfluidics, cell electrospinning) with functional and composite materials for applications in tissue engineering, regenerative medicine, and organs-on-chip. His work focuses on the design, development, optimization, implementation, and characterization of innovative functional biomaterials using emerging engineering technologies, with particular emphasis on cardiac tissue engineering and biomimetic pulmonary heart valves for pediatric patients. Dr. Savoji has published extensively on biomaterials, tissue engineering, 3D bioprinting, and organ-on-chip technologies. His recent publications demonstrate expertise in viscoelastic characterization of soft tissues, engineering immune responses to biomaterials, ceramic engineering for biomedical applications, and advanced 3D bioprinting techniques for cardiac and vascular tissue engineering. 2017-2020, Postdoctoral Research Grant, CIHR 2017-2019, Postdoctoral Research Grant, FRQNT 2017-2018, Human Society of International Grant, Human Toxicity Assessment Project 2016, CR-CHUM Research Center Award 2015, Star Student-Researcher Award, FRQNT 2014-2015, Jane and Frank Warchol Fellowship, Society of Vacuum Coaters Foundation 2013, Institute of Textile Science Award 2012-2015, Excellence Doctoral Scholarship for Foreign Students, FRQNT Dr. Savoji has supervised Master's students including Ines Barrakad (2024) working on 'Advanced manufacturing technologies versus molding of corneal implants: 3D printing vs molding of a Keratoprosthesis' and Zineb Ajji (2023) researching 'Development of perfusable patches by 3D bioprinting for potential application in cardiac tissue regeneration.' He has secured numerous research grants from organizations including CIHR, NSERC, FRQNT, FRQS, MITACS, and others for projects related to 3D bioprinting of cardiac tissues, biomimetic heart valves, and other tissue engineering applications. The Savoji Laboratory, located within the Department of Pharmacology and Physiology and Institute of Biomedical Engineering of the Faculty of Medicine of the University of Montreal, the Research Center of the CHU Sainte-Justine (CHUSJ), and the TransMedTech Institute, focuses on multidisciplinary research involving 3D bioprinting using stem-cell derived human cardiac cells to fabricate functional cardiac tissues for transplantation and drug discovery applications.
Dr. Christina Allen is a Professor of Orthopaedics & Rehabilitation at Yale School of Medicine, where she serves as Chief of Yale Sports Medicine and Vice Chair of Athletic Medicine and Community Outreach. She is the Orthopaedic Team Physician for Yale Athletics and has extensive experience with U.S. national teams, including U.S. Soccer and USA Taekwondo. Education: BS in Biomedical Engineering, Duke University (1983); MD, UCLA School of Medicine (1995) Training: Orthopaedic Residency and Sports Medicine Fellowship, University of Pittsburgh Research Interests focus on: Revision ACL reconstruction outcomes and predictors Meniscus transplantation and cartilage repair Proximal hamstring avulsion repair Quantitative MRI for joint kinematics and cartilage changes Post-ACL revision infection risk factors Scientific Awards include: Kappa Delta Ann Doner Vaughn Award (2019) NIH R01 Competitive Renewal Grant (2017) AOSSM O’Donoghue Award (2014) Clinical Roles span: Team physician for U.S. Soccer (Women's/Men's National Teams) Former team physician for San Francisco Deltas (NASL Champions 2017) Medical Board member, World Taekwondo (London Olympics 2012, Rio Olympics 2016) Publications highlight a 20-year longitudinal focus on: Machine learning models for surgical outcome prediction Graft choice impact on revision ACL longevity Cartilage degeneration after meniscectomy Biomechanical MRI analysis of joint kinematics Infection rates in revision surgeries Return-to-sport protocols for athletes
Professor Hala Zreiqat AM is a leading biomedical engineer at The University of Sydney , serving as the Director of the ARC Training Centre for Innovative BioEngineering . A Fellow of all major Australian academies (AAS, ATSE, FAHMS, FRSN), she develops 3D printed bioceramics for bone regeneration while championing diversity through initiatives like the IDEAL Society and BIOTech Futures mentorship program. Her work bridges academia, clinical practice, and industry in musculoskeletal research . Research Focus: Her lab creates synthetic bone scaffolds that mimic natural bone architecture, strength, and porosity, enabling non-rejected bone regeneration via patient-matched implants. Key applications include orthopaedic, dental, and maxillofacial repair , with over $18M in competitive funding and multiple patents. Current projects explore AI-driven scaffold performance prediction and anti-senescence strategies for aging-related bone loss. Scientific Trends: Recent publications highlight 3D printed nanovoxelated ceramics , antisenescence biomaterials , and multifunctional theranostic platforms . Her team integrates machine learning for scaffold design, atom probe tomography for interface analysis, and two-photon imaging for cellular monitoring in 3D environments. 2021-2022 Fulbright Senior Scholar 2018 NSW Premier's Woman of the Year 2019 Eureka Prize for Innovative Use of Technology Fellow of Australian Academy of Science (2021) Over $18M in research funding Teaching & Leadership: She designed core courses like Tissue Engineering and Nanomaterials in Medicine , mentoring 158 students in 2020 alone. As Chair of CAAR (2020-2023), she strengthens Australia-Arab collaborations. Her lab trains early-career researchers , with alumni now in academia and industry.
Anastassios Karistinos, M.D., is an Assistant Professor in the Department of Orthopedic Surgery at Baylor College of Medicine. He holds clinical roles at Ben Taub Hospital, Baylor Clinic, and the Michael E. DeBakey VA Medical Center in Houston, Texas. Dr. Karistinos completed his medical degree (MD) at Aristotle University of Thessaloniki (1993), followed by residency at Louisiana State University Health Sciences Center (2005) and a fellowship in Advanced Orthopaedics and Sports Medicine (2005). His professional interests focus on complex musculoskeletal conditions including multi-ligament knee injuries, meniscal transplantation, cartilage restoration techniques (OATS, ACI), knee osteotomies, shoulder instability, rotator cuff injuries, and shoulder arthroplasty. He emphasizes patient safety and critical evaluation of emerging medical technologies, prioritizing evidence-based treatments. Dr. Karistinos is certified by the American Board of Orthopaedic Surgery in both Orthopaedic Surgery and Orthopaedic Sports Medicine. He is a Fellow of the American Academy of Orthopaedic Surgeons and specializes in sports medicine, arthroscopic surgery, and trauma care. His research integrates anatomical insights with clinical outcomes to improve surgical techniques and patient recovery processes.
Julie C. Liu is an Associate Professor of Chemical Engineering at Purdue University, with a courtesy appointment in Biomedical Engineering. She joined Purdue in 2008 and holds a B.S.E. from Princeton University, M.S. and Ph.D. from Caltech, and completed a postdoc at the University of Massachusetts Medical School. Her research focuses on protein-based biomaterials for tissue engineering, regenerative medicine, and surgical adhesives, with a particular emphasis on recombinant proteins and natural matrix molecules like collagen and hyaluronic acid. Key awards include the Purdue Faculty Scholar (2019-2024), ELATES Fellowship (2019), and Outstanding Mentor Award (2018). Her work has been funded by NSF, NIH, and industry grants. She advises multiple graduate and undergraduate students, mentoring over 20 researchers. Her lab collaborates on outreach, including Introduce a Girl to Engineering Day, reaching 500+ students since 2014. Liu’s lab designs biomaterials with tailored properties for cartilage repair, drug testing models, and adhesives. Recent advances include mussel-inspired adhesives and redox-responsive hydrogels. She leads a team focused on translational biomedical innovations, bridging engineering and clinical applications.
Christine Clark, MD, MSc is an attending laryngologist at Weill Cornell Medicine’s Sean Parker Institute for the Voice and Assistant Professor in the Department of Otolaryngology-Head and Neck Surgery at Weill Cornell Medical College. She earned her B.A. from the University of Pittsburgh (2011) and her M.D. from Pennsylvania State University College of Medicine (2017), followed by residency at Georgetown University Medical Center and a fellowship in Laryngology at Weill Cornell, where she also obtained a master’s degree in Clinical and Translational Science. B.A. - University of Pittsburgh (2011) M.D. - Pennsylvania State University College of Medicine (2017) Residency - Georgetown University Medical Center Fellowship - Sean Parker Institute for the Voice (Laryngology) Master’s - Clinical and Translational Science at Weill Cornell Dr. Clark specializes in evaluating and treating swallowing, voice, and airway disorders. Her research focuses on chronic cough, laryngeal hypersensitivity, and benign phonotraumatic vocal fold lesions. She has developed clinical tools like the 3D-printed injection laryngoplasty simulator and quality improvement initiatives for surgical airway management. Her clinical work and research span topics such as vocal fold hemorrhage management, pharyngeal residue quantification in dysphagia, and granuloma as markers of malignancy. Recent publications emphasize global otolaryngology capacity building and performer-specific voice injury care. Scientific awards include: Teaching awards for excellence in medical student education during residency Dr. Clark is affiliated with the Sean Parker Institute for the Voice at Weill Cornell Medicine and serves as an Assistant Professor of Otolaryngology.
Dr. Darryl Dickerson is an Assistant Professor in the Department of Mechanical and Materials Engineering at Florida International University (FIU), part of the College of Engineering. His research focuses on mechanical characterization of biological interfaces, design of bioinspired materials, and advancing inclusive engineering education practices. He holds a Ph.D. (details not explicitly provided in text). Research Interests: Dr. Dickerson’s work bridges biomechanics and biomaterials engineering with social equity in education. Key areas include: Mechanical properties of biological interfaces (e.g., bone-cartilage junctions) Development of biomaterials for tissue repair using 3D printing and electrospinning Anti-marginalization strategies in engineering education, particularly for Black and Brown students Publications Trends: Recent work emphasizes dual themes: (1) Biomedical innovation through advanced material fabrication and (2) Inclusive pedagogy addressing systemic inequities in STEM education. Notable contributions include scaffold designs for osteochondral repair and frameworks for reducing microaggressions in team-based learning. Grants and Advising: No specific grants or advisees listed in the provided text. His work appears to be grant-funded through NIH/National Science Foundation pathways common in biomaterials and education research. Labs and Teams: While not explicitly stated, his research likely involves collaborations with FIU’s Center for Engineering and Computing’s diversity initiatives and biomaterials labs focusing on tissue engineering applications.
Lara A. Estroff is a Full Professor and the current Chair of the Department of Materials Science and Engineering at Cornell University's College of Engineering. She has been a faculty member since 2005 and served as Director of Graduate Studies from 2015 to 2019. Her academic leadership and research excellence position her at the forefront of bio-inspired materials and biomineralization research. Her educational background includes a B.A. in Chemistry from Swarthmore College (1997) and a Ph.D. in Chemistry from Yale University (2003), followed by an NIH-funded postdoctoral fellowship at Harvard University in the lab of Prof. George M. Whitesides. Dr. Estroff's research centers on the fundamental mechanisms of crystal growth, biomineralization, and pathological mineralization. She investigates how organisms control mineral formation and applies these principles to engineer synthetic materials with complex structures and functionalities. Her work spans biomaterials, tissue engineering, and energy materials—particularly hybrid organic-inorganic perovskites for photovoltaics. She employs advanced characterization techniques and has pioneered in situ methods to monitor crystallization dynamics. Her recent publications reveal a strong trend toward interdisciplinary research, integrating materials science with cancer biology, immunology, and machine learning. The articles emphasize bio-inspired synthesis, mineral-tissue interactions, and the development of functional crystalline materials for medical and energy applications. Faculty Early CAREER Award, National Science Foundation (2009) Fiona Ip Li '78 and Donald Li '75 Excellence in Teaching Award, Cornell College of Engineering (2007) Marilyn Emmons Williams Award, Cornell Undergraduate Research Board (2009) Keynote Speaker, Gordon Research Seminar on Biomineralization (2012) Lawrence Berkeley National Lab Affiliate (2013) Dr. Estroff leads a major DOE-funded project titled “Formulation Engineering of Energy Materials via Multiscale Learning Spirals,” a $3 million, three-year initiative using machine learning to optimize perovskite synthesis for solar cells. She has advised numerous graduate students and postdoctoral researchers, and her lab is known for fostering collaborative, cross-disciplinary research. She has also contributed to educational initiatives at Cornell, particularly in undergraduate research and materials education. Her research group operates at the intersection of chemistry, engineering, and biology, focusing on high-resolution characterization of biominerals, in situ crystal growth studies, and the design of in vitro models for cell-mineral interactions. The lab actively collaborates with institutions including Lawrence Livermore National Laboratory, National Renewable Energy Laboratory, and Johns Hopkins University.
Dr. Parth Chansoria is a Lecturer at the Department of Health Sciences and Technology at ETH Zürich, where he leads biofabrication research within the Tissue Engineering and Biofabrication (TEB) group. His work focuses on structured light technology for regenerative medicine applications, including in vivo bioprinting and microgravity-based tissue engineering. He holds Ambizione and Spark grants from the Swiss National Science Foundation and has pioneered innovations in light-guided biofabrication, collagen-based resins, and anisotropic tissue design. Research domains include: Filamented light biofabrication for aligned tissues Minimally invasive light-based in vivo bioprinting Musculoskeletal tissue engineering in microgravity Isotonic collagen-based photocrosslinkable resins He has secured over 6 patents and received prestigious awards including the ISBF Early Career Investigator Award (2022), Marie Curie Actions Fellowship (2021), and SME 30 Under 30 recognition (2021). His interdisciplinary research bridges bioengineering, materials science, and clinical applications. Key collaborations include projects at UNC Chapel Hill (USA) and NC State (USA), where he developed biomimetic patches for dynamic organ pathologies and ultrasound-assisted cell patterning. His lab explores novel bioinks, hybrid fabrication techniques, and translational applications in regenerative medicine.
Adam Feinberg is a Professor in the Departments of Biomedical Engineering and Materials Science and Engineering at Carnegie Mellon University (CMU). He leads the Regenerative Biomaterials & Therapeutics Group, focusing on cell-material interactions, 3D bioprinting, and bioengineered tissues. His work integrates nanofabrication, molecular biology, and 3D imaging to address challenges in muscle repair, corneal regeneration, and cancer. Key innovations include the FRESH bioprinting platform, enabling soft ECM gel-based constructs, and ECM shrink-wrapping techniques for cell encapsulation. Feinberg holds a Ph.D. and MS in Biomedical Engineering from the University of Florida (2004, 2002) and a BS in Materials Science and Engineering from Cornell University (1999). He has secured major grants, including ARPA-H funding for diabetes treatments and Canada’s New Frontiers Fund for heart disease therapies. His research has led to over 45 peer-reviewed articles and 20 patents. His scientific awards include the NIH Director’s New Innovator Award and NSF CAREER Award. Media highlights include breakthroughs in vascularized tissue models and biodegradable actuators. Feinberg collaborates widely, advancing clinical translation of bioprinted tissues and sustainable bio-bots.
Mark W Grinstaff is a Professor at Boston University, leading the Grinstaff Group, which focuses on interdisciplinary biomaterials and biomedical engineering research. His work addresses healthcare challenges through innovations in diagnostics, devices, and therapeutics. He holds a B.A. from Occidental College (1987) and a Ph.D. from the University of Illinois at Urbana-Champaign (1992). Research interests include designing biodendrimers for tissue engineering, interfacial biomaterials, and conducting polymer-based sensors. Key areas span cartilage repair, drug delivery systems (e.g., anticancer, DNA), and biodegradable scaffolds. He explores nanoparticle-based imaging agents for osteoarthritis diagnosis and biomechanical assessments using computed tomography. Recent publications highlight advancements in machine learning-driven osteoarthritis classification, dual-contrast agents for cartilage imaging, and synthetic biolubricants for equine models. His group emphasizes translational research, with a focus on nanotechnology, regenerative medicine, and therapeutic delivery platforms. Grinstaff’s work is supported by grants and collaborations, though specific grants are not detailed in the text. He advises students through the Grinstaff Group, though no student names are listed here. His lab develops novel materials and devices, including polymeric adhesives and biosensors, with applications in orthopedics, oncology, and infectious diseases.
University Medical Center Hamburg-EppendorfGermany
Dr. Timur Alexander Yorgan is a prominent researcher at the Department of Osteology and Biomechanics at University Medical Center Hamburg-Eppendorf (UKE). Holding a Dr. rer. nat. degree, he has established himself as a leading figure in bone biology with over 60 publications spanning from 2013 to 2025. His research is deeply integrated with key institutional research areas including the Hamburg Center of Neuroscience and immunology research networks at UKE. Dr. Yorgan's research focuses on skeletal development, bone remodeling, and genetic bone disorders, with particular emphasis on Wnt signaling pathways and their role in bone homeostasis. His work spans multiple approaches from molecular genetics to translational studies, investigating osteoblast and osteocyte biology, genetic mechanisms underlying disorders like osteogenesis imperfecta, and the effects of various mutations on skeletal integrity. Recent research has expanded into the gut-bone axis, mechanobiology of bone cells, and neuro-immune interactions affecting bone metabolism. Analysis of Dr. Yorgan's publication record reveals a consistent trajectory of high-impact research in bone biology. His work increasingly explores interdisciplinary connections between bone metabolism and other physiological systems, with growing emphasis on translational approaches for therapeutic interventions. The research demonstrates sophisticated use of mouse models and molecular techniques to unravel complex bone disorders and identify potential treatment targets. Dr. Yorgan appears to be actively involved in collaborative research across multiple institutions, as evidenced by his extensive publication record with numerous co-authors from various departments and institutions. His work is frequently published in high-impact journals including Journal of Bone and Mineral Research, Nature Communications, and Bone Research. The Department of Osteology and Biomechanics at UKE, where Dr. Yorgan is based, is part of a vibrant research ecosystem that includes the Hamburg Center of Neuroscience and other key research networks focusing on immunology, oncology, and cardiovascular research. This collaborative environment enables interdisciplinary approaches to understanding skeletal disorders and developing novel therapeutic strategies.
Swiss Federal Institute of Technology in LausanneSwitzerland
Peyman Karami is a Postdoctoral Researcher at the Laboratory of Biomechanical Orthopedics (LBO) within École Polytechnique Fédérale de Lausanne (EPFL)'s College of Engineering . Research focuses on adhesive hydrogels for cartilage repair and orthopedic applications Investigates biomimetic stimuli (hydrostatic pressure, temperature) in chondrocyte homeostasis Develops ligin-based multifunctional hydrogels for sustainable biomedical applications Expertise in mechanobiology and thermomechanical regulation of tissue-engineered constructs Scientific Contributions: Leads 15+ publications on hydrogel technologies for cartilage regeneration, thermomechanical stimulation effects, and lignin functionalization, including breakthrough work in NIR-light photocuring , malacic trachea repair , and biomimetic temperature gradients . Current Research Trends: Prioritizes injectable adhesive hydrogels , noninvasive tissue repair , and multi-functional biomaterials that couple mechanical and biochemical cues for enhanced regeneration.
